In a bold move, President Donald Trump signed an executive order that reclassifies marijuana from a Schedule I to a Schedule III drug. This shift aims to ease research restrictions and explore its medical benefits, especially for treating chronic pain. “The executive order the President will sign today is focused on increasing medical research for medical marijuana and CBD,” mentioned a senior administration official ahead of the signing.
The reclassification positions marijuana alongside some common prescription painkillers, marking a significant change in federal policy. This decision follows Trump’s campaign promises to support research into medical marijuana benefits.
A senior official stated, “The President has heard from so many people about the potential benefits of medical marijuana and CBD use.”
This move sparked varied reactions, with many healthcare providers hopeful for improved patient-doctor discussions regarding marijuana use. Public support is evident, as nearly one in four U.S. adults suffers from chronic pain, and many rely on medical marijuana for relief.
While marijuana remains federally illegal without Congressional approval, this executive order could mark a turning point. Will more states follow? The conversation around medical marijuana and its legal status continues.
Sources: ABC News, Senior White House Official